title: Different adhesion and migration properties of human HCV29 non-malignant urothelial and T24 bladder cancer cells: role of glycosylation.
abstract: In tumour cells, alterations in cellular glycosylation may play a key role in their metastatic behaviour. This study used cell lines having very different behaviour in vivo: HCV29 non-malignant transitional epithelium and T24 bladder transitional cell carcinoma. These differences in behaviour might be due in part to differences in cellular glycosylation patterns. Glycan chain analysis of their glycoproteins was performed with the use of specific lectins. The functional role of carbohydrates was studied by treating these cells with swainsonine, an inhibitor of Golgi alpha-mannosidase II, and in vitro adhesion and migration assays. The adhesion of swainsonine-treated HCV29 and T24 cells was increased on fibronectin and type IV collagen by 1.5- and 2-fold, respectively, whereas adhesion on laminin was virtually unchanged after swainsonine-treatment in HCV29 cells and was increased in T24 cells. Swainsonine treatment reduced the rate of T24 cell migration by 20%. We concluded that beta1-6 branched tri- and tetraantennary complex-type glycans have an important function in adhesion and migration in the studied cell lines. These data support the view that oligosaccharides are involved in several steps of the metastatic process.
authors.affiliation: Department of Animal Physiology, Institute of Zoology, Jagiellonian University, Ingardena 6, 30-060 Kraków, Poland. kloc@zuk.iz.uj.edu
authors.forename: M
authors.initials: M
authors.lastname: Przybyło
authors.forename: A
authors.initials: A
authors.lastname: Lityńska
authors.forename: E
authors.initials: E
authors.lastname: Pocheć
mesh_terms: D002448:Cell Adhesion / Q000187:drug effects; D045744:Cell Line, Tumor; D002465:Cell Movement / Q000187:drug effects; D004791:Enzyme Inhibitors / Q000494:pharmacology; D004847:Epithelial Cells / Q000737:chemistry / Q000378:metabolism*; D005260:Female; D006031:Glycosylation / Q000187:drug effects; D006801:Humans; D008297:Male; D011134:Polysaccharides / Q000096:biosynthesis* / Q000737:chemistry; D013045:Species Specificity; D017026:Swainsonine / Q000494:pharmacology; D014513:Ureter / Q000737:chemistry / Q000166:cytology / Q000378:metabolism*; D001749:Urinary Bladder Neoplasms / Q000737:chemistry / Q000378:metabolism* / Q000473:pathology
chemical_list: D004791:Enzyme Inhibitors; D011134:Polysaccharides; D017026:Swainsonine